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The postprandial state is hypothesised to be proinﬂammatory and prooxidative, but the relative contributions of fat versus
carbohydrateareunclear.Therefore,weexaminedinﬂammationandoxidativestressresponsesinserumandskeletalmusclebefore
and after 1000kcal meals, which were high in either fat or carbohydrate in 15 healthy individuals. Serum and muscle expression
of IL6 was elevated 3 hours after each meal, independently of macronutrient composition (P<0.01). Serum IL18 was decreased
after high-fat meal only (P<0.01). Plasma total antioxidative status and muscle Cu/Zn-superoxide dismutase were decreased after
high-carbohydrate meal only (P<0.05). We conclude that a high-carbohydrate meal may evoke a greater postprandial oxidative
stress response, whereas both fat and carbohydrate increased IL6. We speculate that the observed increases in postprandial IL6,
without increases in any other markers of inﬂammation, may indicate a normal IL6 response to enhance glucose uptake, similar
to its role postexercise.
1.Introduction
Inﬂammation and oxidative stress are postulated to impair
beta-cell function and exacerbate insulin resistance in type 2
diabetes [1, 2] and often coexist in atherosclerosis and car-
diovascular disease [3]. Many studies have reported inﬂam-
mation and oxidative stress in the fasting state in obesity
and type 2 diabetes [4–7]. This is usually in the presence of
hyperglycaemia and dyslipidemia, which are known triggers
ofinﬂammatoryandoxidativestresspathways.Incellsandin
animal models, it is becoming apparent that inﬂammatory
cytokines and reactive oxygen species (ROS) contribute to
the early development of insulin resistance [8–10].
Humans spend the majority of their time in the post-
prandi-al state, which is hypothesised to be both proinﬂam-
matory and pro-oxidative and may directly aﬀect insulin
resistance in skeletal muscle, contributing to development
of type 2 diabetes [1, 2]. However, the available literature is
conﬂicting as to whether circulating inﬂammatory cytokines
change in response to meals, although a consensus is gener-
ally reached in respect to stimulation of postprandial IL6
[11–14]. Whether high-fat and high-carbohydrate meals
diﬀerentially modulate the inﬂammatory or oxidative stress
responses in humans is also debated [15, 16]. Therefore, the
aim of this study was to examine circulating and skeletal
muscle gene expression of inﬂammation and oxidative
stress markers in the fasting state and after a physiological
challenge by a high-carbohydrate or high-fat meal in healthy,
non-obese, normoglycemic individuals, 7 of whom reported
a family history of type 2 diabetes.
2. Methods
2.1. Study Population. The study population has been de-
scribed previously [17] and consisted of 15 nonsmoking,
nondiabetic normolipidemic subjects, aged 18–55 years who
reported either no family history (FH−, n = 8) or a strong
family history of type 2 diabetes (FH+, n = 7). Subjects
were excluded if weight changed by ≥2kg in the preceding 6
months, if they drank more than 2 standard alcoholic drinks
per day, if they were taking any medications known to aﬀect
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or cardiovascular disease. The study was approved by the
Human Research Ethics Committee at St. Vincent’s Hospital,
Sydney, and each subject gave written consent prior to the
start of the study.
2.2. Study Design and Procedures. A randomized, paired,
crossover design was used. On the ﬁrst visit, a hyperinsu-
linaemic-euglycaemic clamp (50mU·m−2·min−1)a n da
dual energy X-ray absorptiometry (DXA) scan (Lunar
DPX-Lunar Radiation, Madison, WI) were performed to
assess insulin-sensitivity and body composition, respectively.
At visits 2 and 3, which were performed at least 3 days
and no more than 2 weeks apart, a meal rich in either
carbohydrate or fat was consumed after a prolonged (20h)
fast (randomly assigned) (Table 2). In the high-fat meal,
34% of fat was saturated, 29% polyunsaturated, and 38%
monounsaturated. The subjects were instructed not to
consume alcohol 24h prior to every study day. Biopsies from
musculus vastus lateralis were taken fasting and 3h after
meal. Blood samples for analysis of circulating inﬂammatory
markersofinterestwerealsoassessedatbaselineand3hafter
meal. Glucose, insulin, free fatty acid (FFA), and triglyceride
concentrations were assessed at 0, 30, 60, 120, 180, and 240
minutes after completion of the meal.
2.3. Biochemical Analysis. Skeletal muscle expression of the
following genes was studied: complement component C3
(C3), tissue-type plasminogen activator (PLAT), human
forkhead-box C2 gene (FOXC2), nuclear factor kappa B
(NFKB1), inhibitor of nuclear factor kappa B kinase beta
subunit (IKBKB), hypoxia inducible factor 1, alpha sub-
unit (HIF1α), IL6, heme-oxygenase-1 (HMOX1), endothelial
nitric oxide synthase (NOS3), heat shock 70kDa protein
(HSPA1A), Cu/Zn-superoxide dismutase (SOD1), and glu-
tathione peroxidase (GPX1). Muscle RNA was extracted as
described [18]. Brieﬂy, cDNA was prepared from RNA by
use of Superscript II and oligo dT primers (Invitrogen, VIC,
Australia). Most primers were designed using MacVector
(Sigma Aldrich, Castle Hill, NSW, Australia), except for
IL6, HMOX1, HSPA1A, NOS3, SOD1,a n dGPX1,w h i c h
were purchased as pre-made primer-probe sets from Applied
Biosystems (NSW, Australia). Real-time quantitative PCR
wasperformedwiththe 7900HT Fast Real-TimePCRSystem
(Applied Biosystems, NSW, Australia) with Power SYBR
Green PCR Master Mix or TaqMan Universal Master Mix, as
appropriate (Applied Biosystems, NSW, Australia), accord-
ing to the manufacturer’s instructions. The Ct value for
every sample was measured in duplicate and was normalized
to beta actin (ACTB) expression, which was not diﬀerent
between groups at baseline and was not altered in response
to either meal.
Circulating levels of C-reactive protein (CRP), serum
amyloid A (SAA), and TNFα were determined in duplicate
at baseline and 3h, using LincoPlex multiplex immunoassay
(Linco Research Inc., St Charles, MO), and the intra-assay
CVs were 6%, 8%, and 7%, respectively. Serum IL6 and
IL18 were determined using highly sensitive ELISA kits
(R&D Systems Inc., MN, USA) and the intra-assay CVs
were 8% and 7%, respectively. Insulin and total adiponectin
concentrations were measured by RIA (Linco Research, St
Charles, MO). Total antioxidant status (TAS) was analyzed
by a colorimetric assay kit (Calbiochem, Merck, Germany)
with an intra-assay CV of 7% and plasma Cu/Zn-SOD by
an ELISA kit (Calbiochem, Merck, Germany) with an intra-
assay CV of 5%.
2.4. Statistical Analysis. Data is presented as mean ± SEM.
Statistics were analysed with StatView 5.0 (SAS Institute,
Cary, NC). Basal diﬀerences between the groups were
evaluated by student’s t-test, and repeated-measures ANOVA
was used to determine diﬀerences in response to the meal
by group and time. Paired t-test analysis was performed
to evaluate the eﬀect of meal in the whole cohort when
no group eﬀect was observed. Correlations were performed
using Pearson’s correlation coeﬃcient. Signiﬁcance was set at
P ≤ 0.05.
3. Results
3.1. Baseline and Postprandial Characteristics by FH Status.
As we have previously reported in this cohort, individuals
with (FH+) and without (FH−) a family history of diabetes
had similar BMI, body fat composition by DXA, serum
lipid proﬁles, and insulin sensitivity as assessed by glucose
infusion rate necessary to maintain euglycemia during the
ﬁnal 30 minutes of the hyperinsulinemic clamp (Table 1).
Fasting levels of insulin, glucose, and triglycerides were also
not signiﬁcantly diﬀerent between FH+ and FH−, and there
was no diﬀerence in the incremental areas under the curve
forglucose, FFA,and triglyceride response to either the high-
fat or high-carbohydrate meals. However, FH+ had a greater
insulinemic response to both the high-carbohydrate and
high-fat meal compared with FH− (Table 1, P<0.02). Since
we did not detect diﬀerences between groups at baseline or
in response to meals for any markers of inﬂammation and
oxidative stress, except for increased baseline HMOX1 gene
expression in FH+ (6.0 ± 1.0A Uv e r s u s2 .7 ± 0.3A U ,
P = 0.03), groups are combined for reporting by meal-type
below.
3.2. High-Carbohydrate versus High-Fat Meal Response. As
expected, glucose and insulin responses were higher (Figures
1(a) and 1(b))a n dF F A( Figure 1(c)) lower after the high-
carbohydrate versus the high-fat meal and triglyceride
concentration was raised more after the high-fat meal
(Figure 1(d)). Plasma IL6 was elevated by 30–40% at 3 hours
after each meal, independently of meal type (P<0.05,
Figure 2(a)). A positive relationship was observed between
the change in circulating IL6 and change in insulin following
the high-carbohydrate meal (R2 = 0.28, P = 0.04).
Circulating IL18 was decreased after the high-fat meal only
(P<0.01, Figure 2(b)). The systemic levels of CRP, TNFα,
adiponectin, and serum amyloid A were not changed by
either meal type (data not shown).
Skeletal muscle IL6 expression increased by more than
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Table 1: Baseline characteristics of study participants with (FH+)
and without (FH−) a family history of T2D.
FH− FH+
N (Male/Female) 7 (2/5) 8 (2/6)
Age (years) 41 ± 34 7 ± 2
Weight (kg) 75.5 ± 5.56 9 .5 ± 3.3
BMI (kg/m2)2 6 .5 ± 2.12 6 .0 ± 1.9
Total body fat (%) 36 ± 43 6 ± 4
Abdominal fat (kg) 2.5 ± 0.41 .9 ± 0.3
Total cholesterol (mmol/L) 4.6 ± 0.35 .1 ± 0.2
HDL cholesterol (mmol/L) 1.2 ± 0.08 1.3 ± 0.07
LDL cholesterol (mmol/L) 2.9 ± 0.23 .2 ± 0.15
Triglycerides (mmol/L) 1.1 ± 0.21 .3 ± 0.2
GIR (μmol min−1/kg FFM) 78.7 ± 9.37 3 .5 ± 9.2
Glucose iAUC (CHO) 429 ± 65 492 ± 55
Glucose iAUC (Fat) 43 ± 13 53 ± 16
Insulin iAUC (CHO) 15924 ± 3190 31081 ± 3993∗
Insulin iAUC (Fat) 1895 ± 392 3379 ± 322∗
Data are given mean ± SEM, GIR: Glucose infusion rate necessary to
maintain euglycemia during the hyperinsulinemic clamp; AUC: area under
the curve, ∗P<0.02.
Table 2: Food items (grams) and the macronutrient compositions
of the high-fat and carbohydrate meals.
Item Protein Fat CHO
High-carbohydrate meal
Weetbix cereal (60g) 7.2 0.8 40
No fat milk (300mL) 14.4 0.3 20.2
Spaghetti, tinned (1 cup) 5.1 3 34
Margarine (5g) 0 4 0
Orange juice (25mL) 1 0 25
Wholemeal bread (75g) 7.5 1.3 33.5
Banana (150g) 1 0 30
Total (g) 36.2 9.4 182.7
Energy (kJ) 605 353 3051
E% 15.1 8.8 76.1
High-fat meal
Cheese (44g) 11 15.4 0
Eggs (118g) 14.2 11.8 0
Oil (20mL) 3 20 0
White bread (30g) 0 0.5 13
Tomato (100g) 0 0 3
55% cream (30mL) 0 16.5 0
Strawberries (100g) 0 0 3
Almonds (30g) 6 15 1
Total (g) 34.2 79.2 20
Energy (kJ) 571 2978 334
E% 14.7 76.7 8.6
between meals (P<0.005, Figure 2(c)). The other inﬂam-
mation markers measured in skeletal muscle (C3, FOXC2,
IKBKB,andNFKB1)werenotchangedwitheithermeal(data
not shown).
In response to the high-carbohydrate meal, total antioxi-
dant status (TAS) decreased (P = 0.03, Figure 3(a)), without
change in response to the high-fat meal. Plasma levels
of the antioxidative enzyme Cu/Zn-SOD were unchanged
(Figure 3(b)), although its expression in muscle decreased
in response to the high-carbohydrate meal (P = 0.02,
Figure 3(c)). The skeletal muscle expression of HIF1α,
HMOX1, NOS3, HSPA1A,a n dGPX1 did not change with
either meal (data not shown).
3.3. Relationships between Insulin Sensitivity or Fatness, and
Inﬂammation and Oxidative Stress. We observed relation-
ships between CRP and BMI (r = 0.56, P = 0.03) and fasting
levels of circulating IL6 also tended to correlate with BMI
(r = 0.51, P = 0.06). However, no other relationships were
observed for other inﬂammatory markers either in fasting
state or after the meal. Of the oxidative stress markers exam-
ined, only muscle expression of GPX1 positively correlated
with BMI (r = 0.4, P = 0.04).
4. Discussion
The aims ofthe presentstudy wereto(i)examine theinﬂam-
matory and oxidative stress response to meals in a healthy
nondiabetic cohort and (ii) to compare responses between
healthy normoglycemic individuals with and without a
family history of type 2 diabetes. The study established that
there was a substantial elevation in both circulating and
muscle gene expression of IL6, independently of the type of
mealconsumedandwithoutincreasesinanyothermeasured
inﬂammatory markers.
Evidence surrounding proinﬂammatory eﬀects of meals
is controversial. Some meal studies have reported a proin-
ﬂammatory response, indicated by an increase in endotox-
emia [19], activation of blood leukocytes [20], induction
of nuclear proinﬂammatory transcription factors [21]a n d
increased CRP [11]. In contrast, others observed no change
in adiponectin, CRP, and C3 and a decrease in circulating
TNFα [13, 14]. These discrepancies may be a result of diﬀer-
ences in meal composition, energy content, and particularly
theadiposityanddiseasestatusofthepopulationstudied.We
conﬁrm the most consistent ﬁnding amongst these reports,
a postprandial increase in circulating IL6, and we conﬁrm
that this is independent of macronutrient composition of the
meal [11, 14]. We also extend previous ﬁndings by showing
that the increase in circulating IL6 was due, at least in part,
to increased skeletal muscle expression, with a >1000-fold
increase in mRNA detected in this tissue.
ChronicelevationofsystemicIL6inhumansisassociated
with type 2 diabetes, obesity, and sedentary lifestyle and may
be attributable to increased number of macrophages residing
intheadiposetissue[22].Incontrast,exercisetrainingcauses
an acute elevation in circulating IL6 released from muscle
during contraction which has been reported to stimulate4 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
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Figure 1:Levelsofplasma(a)insulin,(b)glucose,(c)freefattyacid(FFA),and(d)triglyceridesfastingandinresponsetohigh-carbohydrate
or high-fat meals. Footnote: statistics were performed by repeated measure ANOVA.
glucose uptake [23, 24]. Thus, the source of IL6, namely,
adipose tissue versus skeletal muscle and the chronic versus
pulsatile response in obese and/or diabetic versus healthy
subjects may explain the controversies regarding the role of
IL6 in human health and disease [25]. It is well recognised
that obese- and insulin-resistant subjects with chronic low
grade inﬂammation improve glycaemia in concert with a
reduction in cytokines levels following interventions such as
weight loss [22]. However, reducing IL6 levels, in the absence
of adipose tissue inﬂammation may be ineﬀective. Since the
muscle IL6 response was observed in all individuals, and in
the absence of any increases in inﬂammatory markers, we
speculate that the meal-related release of IL6 is physiologi-
cal and may enhance glucose uptake. In support of this
hypothesis, intravenous IL6 infusion during the hyperinsu-
linemic clamp increases glucose disposal in healthyindividu-
als [26], similar to the eﬀects of IL6 during exercise [23].
Interestingly, both continuous and intermittent administra-
tion of IL6 to rats increases insulin sensitivity via mito-
chondrial uncoupling and enhanced skeletal muscle fat
oxidation capacity [27]. Moreover, the IL6 global knockout
mouse model is insulin-resistant, whilst the IL6 transgenic
mouse is protected from diet-induced obesity and insulin-
resistance [28]. In this study, none of the variables examined
were related to the increase in muscle IL-6 expression.
However, we clarify that a positive relationship was observed
between the increase in serum insulin and serum IL6 in
response to the high-carbohydrate meal only. This may
indicate that more insulin resistant subjects have greater IL6
responses. This result is in contrast to Dixon et al., who com-
pared the serum IL6 response to a mixed meal in active and
inactive men. In this study, the increase in serum IL-6 was
not diﬀerent between groups, despite signiﬁcantly higher
glucose and insulin responses in the sedentary men [29].
Together, we propose these ﬁndings support a beneﬁcial
physiological postprandial role of IL6 in healthy individuals.J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 5
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Figure 2: Circulating and muscle gene expression of inﬂammatory markers in the fasting state and 3 hours after either high-carbohydrate
or high-fat meals. Footnote: statistics were performed by Student’s t-test, ∗P<0.05.
IL18isproinﬂammatoryandlevelsareelevatedinobesity
and type 2 diabetes [30–32] and are correlated with traits
of the metabolic syndrome [33]. Knockout of IL-18 or its
receptor results in obesity and insulin resistance [34], and
fasting IL-18 levels are reduced following weight loss in
humans [35]. However, whether these levels are changed in
response to a meal is unclear. In this study, the high-fat
meal produced a small reduction in circulating IL18, but no
changes in IL18 following the high-carbohydrate meal. This
is in contrast to Esposito et al. [36], who observed increased
IL18 after the high-fat meal and decreased IL18 after a high-
carbohydrate meal in 60 individuals with and without type
2 diabetes. The reason for the discrepancies between studies
is unclear. In vitro studies have shown that intermittent
and sustained hyperglycaemic exposure of 3T3L1 adipocytes
increases the secretion of IL18. This occurs in concert with
increased ROS production, both of which were blocked
with the antioxidant N-acetylcysteine suggesting that ROS
generation may mediate hyperglycaemic elevations in IL18.
The postprandial phase has been described as pro-
oxidative [15, 16, 37–39] with the magnitude of the oxidative
stress response linked to the carbohydrate content of the
meal and the level of hyperglycaemia and hyperinsulinemia
evoked [16]. However, data gathered in obese humans has
been controversial, with studies reporting either increased
[35] or decreased [40] ROS emission from skeletal mus-
cle mitochondria ex vivo in the postprandial state. In
the present study, plasma TAS levels were decreased in
response to the high-carbohydrate meal only, suggesting
increasedconsumptionofantioxidative moleculesassociated
with hyperglycaemia-induced oxidative stress [16]. Muscle
expression of Cu/Zn-SOD was also decreased in response
to the high-carbohydrate meal, but the plasma levels were
unchanged. In this study, we focussed on the antioxidative
responsetomeals,ratherthanassessingmarkersofoxidative-
stress-induced damage. Based on the ﬁndings observed here,
we predict that markers of lipid peroxidation, including
the thiobarbituric acid reactive substances (TBARS) or
malondialdehyde (MDA) assays, would increase following a
high-carbohydrate meal, but not following high-fat meals.
Individuals with a family history of type 2 diabetes have
a 40% lifetime risk of developing T2D with a 20% risk of
developing glucose intolerance (1) and thus are an excellent
human model to detect factors that contribute to the early
development of insulin resistance. Previously, in this cohort,
we have reported metabolic inﬂexibility in response to a
high-fat meal (2) and a blunted peptide YY (PYY) increment
in response to a high-carbohydrate meal (3), both of which6 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
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Figure 3: Fasting and 3-hour levels of (a) plasma total antioxidant status (TAS), (b) plasma Cu-Zn superoxide dismutase, and (c) Cu-Zn
superoxide dismutase expression in skeletal muscle in response to high-carbohydrate or high-fat meals. Footnote: statistics were performed
by paired t-test, ∗P ≤ 0.05, ∗∗P ≤ 0.01.
may contribute to later insulin resistance, weight gain, and
eventual T2D. However, in this study, the basal and post-
prandial inﬂammatory and oxidative stress measures were
not diﬀerent between FH+ and FH−, with the exception
of elevated basal expression of muscle heme-oxygenase-1
(HMOX1), which was increased in FH+. Therefore, it may
be that diﬀerences in inﬂammatory and oxidative stress
responses are acquired later in the life course of type 2
diabetes.However,duetothesmallgroupsizecautionshould
be exercised in making this interpretation.
The reports on HMOX1 in type 2 diabetes are contro-
versial. Some studies reported increased circulating levels of
plasma HMOX1 [41] and gene expression of HMOX1 in
circulatingmonocytes[42]intype2diabetes,withreduction
in some individuals after metabolic normalisation. However,
other studies have reported reduced levels of HMOX1 in
muscle and leukocytes at a late stage of type 2 diabetes
patients [43]. Administration of the HMOX1 inducer, hem-
in, improves glucose metabolism in Zucker diabetic rats
and streptozotocin rats (39), and HMOX1 upregulation
improves fasting and postprandial glucose in humans [44].
Together,thesedatasuggestthatfastingmuscleHMOX1may
be upregulated to protect against oxidative-stress-induced
insulin resistance, a response that may be lost in type 2
diabetes.
In conclusion, macronutrient composition of the diet
maydiﬀerentiallyalterthepostprandialpro-oxidativemilieu,
with high-carbohydrate meals potentially leading to greater
oxidative stress response. However, both meals increased
circulating IL6, regardless of the type of nutrient consumed.
Our data suggests that the source of this increase was skeletal
muscle, and since this was observed in absence of other in-
ﬂammatory changes, we propose that IL6 release is part
of healthy postprandial muscle metabolism, similar to that
reported in the postexercise state.
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